More delays in GTG-Applera case
Monday, 05 December, 2005
Two deadlines have come and gone, and a third expires today for Melbourne gene-testing company Genetic Technologies (ASX:GTG; NASDAQ:GENE) and US firm Applera, who were due to announce a resolution of their licensing dispute in California today.
GTG has been pursuing its US rival in the US District Court of Northern California for a licensing fee and royalties for its patented technologies, which uses 'junk DNA' markers to identify haplotypes associated with disease.
The case was originally due to be resolved by a court-sanctioned agreement on November 9, but the companies postponed their execution of a binding settlement, and licence and supply issues until November 25. When November 25 passed, Judge Joseph Spero approved a requested delay until December 5.
After a telephone conference with both parties, Judge Spero has now granted a further extension to Wednesday, December 8, and ordered lawyers and company representatives to attend a further settlement conference in San Francisco.
GTG said the delay was "a positive development in the progress of this matter
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
